Bevacizumab Biosimilar Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 52010 | Published Date: May 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL BEVACIZUMAB BIOSIMILAR INDUSTRY
    2.1 Summary about Bevacizumab Biosimilar Industry
    2.2 Bevacizumab Biosimilar Market Trends
        2.2.1 Bevacizumab Biosimilar Production & Consumption Trends
        2.2.2 Bevacizumab Biosimilar Demand Structure Trends
    2.3 Bevacizumab Biosimilar Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 100mg
        4.2.2 400mg
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Colorectal Cancer
        4.3.2 Lung Cancer
        4.3.3 Breast Cancer
        4.3.4 Renal Cancer
        4.3.5 Brain Cancer
        4.3.6 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 100mg
        5.2.2 400mg
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Colorectal Cancer
        5.3.2 Lung Cancer
        5.3.3 Breast Cancer
        5.3.4 Renal Cancer
        5.3.5 Brain Cancer
        5.3.6 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 100mg
        6.2.2 400mg
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Colorectal Cancer
        6.3.2 Lung Cancer
        6.3.3 Breast Cancer
        6.3.4 Renal Cancer
        6.3.5 Brain Cancer
        6.3.6 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 100mg
        7.2.2 400mg
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Colorectal Cancer
        7.3.2 Lung Cancer
        7.3.3 Breast Cancer
        7.3.4 Renal Cancer
        7.3.5 Brain Cancer
        7.3.6 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 100mg
        8.2.2 400mg
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Colorectal Cancer
        8.3.2 Lung Cancer
        8.3.3 Breast Cancer
        8.3.4 Renal Cancer
        8.3.5 Brain Cancer
        8.3.6 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 100mg
        9.2.2 400mg
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Colorectal Cancer
        9.3.2 Lung Cancer
        9.3.3 Breast Cancer
        9.3.4 Renal Cancer
        9.3.5 Brain Cancer
        9.3.6 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Pfizer
        10.1.2 Allergan
        10.1.3 Amgen
        10.1.4 Biocon
        10.1.5 Reliance lifesciences
        10.1.6 Bevacizumab
        10.1.7 Beaconpharma
        10.1.8 Celgene Corporation
        10.1.9 Fujifilm Kyowa Kirin Biologics
        10.1.10 Hetero Drugs
    10.2  Bevacizumab Biosimilar Sales Date of Major Players (2017-2020e)
        10.2.1 Pfizer
        10.2.2 Allergan
        10.2.3 Amgen
        10.2.4 Biocon
        10.2.5 Reliance lifesciences
        10.2.6 Bevacizumab
        10.2.7 Beaconpharma
        10.2.8 Celgene Corporation
        10.2.9 Fujifilm Kyowa Kirin Biologics
        10.2.10 Hetero Drugs
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Bevacizumab Biosimilar Product Type Overview
Table Bevacizumab Biosimilar Product Type Market Share List
Table Bevacizumab Biosimilar Product Type of Major Players
Table Brief Introduction of Pfizer
Table Brief Introduction of Allergan
Table Brief Introduction of Amgen
Table Brief Introduction of Biocon
Table Brief Introduction of Reliance lifesciences
Table Brief Introduction of Bevacizumab
Table Brief Introduction of Beaconpharma
Table Brief Introduction of Celgene Corporation
Table Brief Introduction of Fujifilm Kyowa Kirin Biologics
Table Brief Introduction of Hetero Drugs
Table Products & Services of Pfizer
Table Products & Services of Allergan
Table Products & Services of Amgen
Table Products & Services of Biocon
Table Products & Services of Reliance lifesciences
Table Products & Services of Bevacizumab
Table Products & Services of Beaconpharma
Table Products & Services of Celgene Corporation
Table Products & Services of Fujifilm Kyowa Kirin Biologics
Table Products & Services of Hetero Drugs
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Bevacizumab Biosimilar Market Forecast (Million USD) by Region 2021f-2026f
Table Global Bevacizumab Biosimilar Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Bevacizumab Biosimilar Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Bevacizumab Biosimilar Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Bevacizumab Biosimilar Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bevacizumab Biosimilar Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bevacizumab Biosimilar Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bevacizumab Biosimilar Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Bevacizumab Biosimilar Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Bevacizumab Biosimilar Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Bevacizumab Biosimilar Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 400mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Renal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 400mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Renal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 400mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Renal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 400mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Renal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 400mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Renal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 400mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colorectal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Renal Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brain Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Allergan 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Amgen 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Biocon 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Reliance lifesciences 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Bevacizumab 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Beaconpharma 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Celgene Corporation 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Fujifilm Kyowa Kirin Biologics 2017-2020e
Figure Bevacizumab Biosimilar Sales Revenue (Million USD) of Hetero Drugs 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Bevacizumab Biosimilar Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bevacizumab Biosimilar Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bevacizumab Biosimilar Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports